Sandbox Reserved 966

From Proteopedia

(Difference between revisions)

Revision as of 13:02, 9 January 2015

This Sandbox is Reserved from 15/11/2014, through 15/05/2015 for use in the course "Biomolecule" taught by Bruno Kieffer at the Strasbourg University. This reservation includes Sandbox Reserved 951 through Sandbox Reserved 975.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Structure of the "Clostridium botulinum" neurotoxin serotype A light chain with Zn2+ cofactor bound

The Clostridium botulinum neurotoxin produced by the bacteria Clostridium botulinum (and some strains of Clostridium butyricium and Clostridium baratii) is the most lethal toxin known today. Seven serotypically botulinum neurotoxins (BoNTs) have been found, each of them is categorized into subtypes depending on their amino acid sequence. The protein is initially synthesized as a single polypeptide chain of ≈150 kDa and is then cleaved by a protease to yield the mature toxin, which consists of a light chain (LC which is 50 kDa) and a heavy chain (HC which is 100 kDa). LC and HC are held together by a long peptide belt, non-covalent interactions and a single inter-chain disulphide bond ^[1]

The Clostridium botulinum neurotoxin serotype A light chain (BoNT/A-LC) shown below is composed of 425 residues. It was obtained with high resolution X-ray crystal structure using an inhibitory peptide and the catalytic Zn(II) ion. ^[2]

1 Structure
- 1.1 Global aspect
- 1.2 Structural highlights
2 Mechanism
3 Therapeutic applications
4 References

Structure

Global aspect

Figure 1 : Ramachandran diagram of C.botulinum neurotoxin serotype A light chain (made using Python by Rémi Pelletier)

The of BoNT/A-LC^[3]

The light chain of Clostridium botulinum neurotoxin serotype A has 11 α-helices :
- Helix 1 :
- Helix 2 :
- Helix 4 :
- Helix 5 :
- Helix 6 :
- Helix 7 :
- Helix 8 :
- Helix 9 :
- Helix 10 :
- Helix 11 :
- Helix 12 :

It also has three 3-10 helices :
- Helix 3 :
- Helix 13 :
- Helix 14 :

structure classique de coude : vers 136 (à faire plus tard)

Structural highlights

Mechanism

Therapeutic applications

In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process. First, they try to treat strabismus and in the late 1970s the neurotoxin is used in many therapeutic applications. REFERENCE ?

hyperhidrosis and CHARGE syndrome

We can now treat excessive sweating with botulinium toxin ^[4] thanks to its action on the receptors of the parasympathetic network. Excessive dribbling can be treated in the same way.

Cosmetic

Non-lethal amount of botulinum toxin can be injected localy to paralyse targeted muscles and reduce wrinkles temporaly^[5] (5 to 6 months).

Blepharospesm, nystagmus, torticollis and strabismus

This pathologic can be treated by the same methode. Every anomalous behaviour of muscle tissue can be fixed thanks to the paralyzing effect of the toxin. It is based on the muscles relaxation.

Cervical dystonia

BTX-A is used against cervical dystonia. But it can become inefficient after a periode of use.

References

↑ Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol. 2014 Aug;12(8):535-49. doi: 10.1038/nrmicro3295. Epub 2014 Jun, 30. PMID:24975322 doi:http://dx.doi.org/10.1038/nrmicro3295
↑ Silvaggi NR, Wilson D, Tzipori S, Allen KN. Catalytic features of the botulinum neurotoxin a light chain revealed by high resolution structure of an inhibitory peptide complex. Biochemistry. 2008 May 27;47(21):5736-45. Epub 2008 May 6. PMID:18457419 doi:10.1021/bi8001067
↑ http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3BON&bionumber=1
↑ http://rms.medhyg.ch/numero-200-page-870.htm
↑ http://rms.medhyg.ch/numero-200-page-870.htm

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_966"

@@ Line 9: / Line 9: @@
 {|
-| [[Image:ramachandran3BON.png|left|200px]]
+| [[Image:ramachandran3BON.png|thumb|'''Figure 1 :''' Ramachandran diagram of C.botulinum neurotoxin serotype A light chain (made using Python by Rémi Pelletier)]]
-| [[Image:Mecanismefinal.jpg|left|200px]]
+|
 |}
 The <scene name='60/604485/Secondary_structure/1'>Secondary structure</scene> of BoNT/A-LC<ref>http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=3BON&bionumber=1</ref>
@@ Line 36: / Line 36: @@
 === Structural highlights ===
 == Mechanism ==
+[[Image:Mecanismefinal.jpg|left|200px]]
 == Therapeutic applications ==
 In the late 1960s, a Edward Schantz and a San Francisco opthalmologist, Alan Scott, start to work on the using of the botulinum toxin in therapeutic process.